Haematological Indices of HIV Infected Antiretroviral-naïve Children in Port Harcourt, Nigeria
Abstract
AIM Even though haematological abnormalities are common manifestations of HIV infection, few studies on haematological parameters in HIV-infected children have been carried out in sub-Saharan Africa. The aim of this study was to assess the haematological parameters in HIV-infected antiretroviral-naïve children attending the Infectious Disease Clinic of the University of Port Harcourt Teaching Hospital.
METHODS A prospective cross-sectional study which was carried out in children aged 5 -16 years attending the Infectious Disease Clinic of University of Port Harcourt Teaching Hospital over a two year period. The control population was HIV negative age and sex matched children. Haematological indices and CD4+ count were done at first visit as part of our routine workup. Patients were classified based on severity of their disease state in accordance with the WHO Clinical Staging of HIV/AIDS. The haematologic indices were estimated by automation and the CD4+ T lymphocytes were counted by flow cytometre. Antibodies to HIV were confirmed by two positive Rapid Diagnostic Test.A P value less than 0.05 was considered significant.
RESULTS One hundred and seven HIV infected antiretroviral naïve children were seen during this period. There were more females 66 (61.7%) than males 41 (38.3%). Most 52 (48.6%) of the mothers had secondary level of education while 35 (32.7%) and 20 (18.7%) had primary and tertiary levels of education respectively. The mean age was 7.4±1.34 years (range, 5-16 years). Haematological indices showed haematocrit of 26.98±0.70 (P=0.004); lymphocyte of 57.90±56 (P=0.13) and platelet of 86.95±16.59 (P=0.01). Most 79 (73.8%) of patients had moderate to severe immunosuppression. The mean CD4 count was 239.34±22.21 (P=0.01).
CONCLUSION This study has demonstrated that most children with HIV infection presented with significant anaemia, thrombocytopenia and moderate to severe immunosuppression
Keywords
References
Rudnicka D, Schwartz O. Intrusive HIV-1-infected cells. Nat Immunol 2009;10:933–4.
Steinman RM, Granelli-Piperno A, Pope M, et al. The interaction of immunodeficiency viruses with dendritic cells.Curr Top MicrobiolImmunol 2003;276:1–30.
Lekkerkerker AN, van Kooyk Y, Geijtenbeek TB. Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res 2006;4:169–76.
Anastos K, Shi Q, French A, Levine A, Greenblatt RM, Williams C et al. Total lymphocyte count, hemoglobin and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1 infected women receiving highly active antiretroviral therapy. J Acquir Immune DeficSyndr 2004;35:383–92.
Ajayi AO, Ajayi EA, Fasakin KA. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria. Ann Afr Med 2009;8:257–60.
Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449–70.
Obirikorang C, Yeboah FA. Blood hemoglobin measurements as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci 2009;16:102
Aboulafia DM, Mitsuyasu RT. Hematologic abnormalities in AIDS. HematolOncolClin North Am 1991;5:195.
Ram Y, Ellen GC. Acquired Immunodeficiency syndrome (Human immunodeficiency virus). In: Behrman RE, Kliegman RM, Jenson HB.(eds). Nelson textbook of pediatrics 18th Edition W.B. Saunders Company 2007; chapter 275 : 876-879
Mata-MarÃn JA, Gaytán-MartÃnez JE, MartÃnez-MartÃn RE, et al. Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study. BMC Res Notes 2010;3:230
Levine A, Karim R, Mack W, Gravink DJ, Anastos K, Young M. et al. Neutropenia in human immunodeficiency virus infection: data from the Women’s Interagency HIV Study. Arch Intern Med 2006;166:405 10.
Miguez-Burbano MJ, Jackson J Jr, Hadrigan S. Thrombocytopenia in HIV disease: clinical relevance, physiopathology and management. Curr Med Chem Cardiovasc Hematol Agents 2005;3:365–76.
Kirchhoff F, Silvestri G. Is Nef the elusive cause of HIV-associated hematopoietic dysfunction? J Clin Invest 2008;118:1622–5.
Dilkshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of haematological abnormalities of Indian HIV infected individuals. BMC Blood Disorders 2009;9:5.
Siegfried N, Uthaman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev 2010;(3): CD008272.
Wisaksana R, Sumantri R, Indrati AR, Alisjahbana B, Jusuf H, Sudjana P, et al. Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infect Dis 2011;11:213.
Dacie JV, Lewis SM. Practical Haematology, 9th ed. Churchill Livingstone, London, 2001; 19-56.
Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). SeminHematol 1988 Jul;25(3):208-18.
Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serumimmunoreactive erythropoietin in HIV-infected patients. JAMA. 1989 Jun;261(21):3104-7
Stella CC, Ganser A, Hoelzer D. Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest. 1987 Aug;80(2):286-93
Hawkins CC, Gold JW, Whimbey E, Kiehn TE, Brannon P, Cammarata R, Brown AE, Armstrong D. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Aug;105(2):184-8
Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex.A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul;317(4):192-7
Toy PT, Reid ME, Burns M. Positive direct antiglobulin test associated with hyperglobulinemia in acquired immunodeficiency syndrome (AIDS). Am J Hematol. 1985 Jun; 19(2):145-50
Sullivan PS, Hanson DL, Chu ST. Surveillance for thrombocytopenia in persons infected with HIV results from the multistate adult and adolescent spectrum of disease project J. Acquir. Immuno Deficiency Syndrome 1992;28:769-10
Sullivan PS, Hanson DL, Chu SY, Jones JL, Ciesielski CA. Surveillance for thrombocytopenia in persons infected with HIV: results from the multistate Adult and Adolescent Spectrum of Disease Project. J Acquir Immune DeficSyndr Hum Retrovirol. 1997;14:374-9.
Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection. Annu Rev Immunol. 2003;21:265-304.
Watanabe T. HTLV-1-associated diseases. Int J Hematol. 1997;66:257-278.
Ashton LJ, Carr A, Cunningham PH, Roggensack M, McLean K, Law M, Robertson M, Cooper DA, KaldorJM . Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. AIDS Res Hum Retroviruses 1998;14(2):117-21
AtzoriC . In Vitro activity of HIV protease inhibitors against Pneumocystis carinii. J Infect Dis 2000; 181:1629-1634.
Popovic M., Sarngadharan M.G., Read E. and Gallo R.C. Detection isolation and continuous production of cytopathic retroviruses (HTLV-111) from patients with AIDS and pre-AIDS. Science 1984; 224: 497-500.
Amballi AA, Ajibola A, Ogun SA: Demographic pattern and haematological profile in people living with HIV in a university teaching hospital. Sci Res Essay 2007, 2(8):315-318.
Erhabor O, Ejele OA, Nwauche CA, Buseri FI. Some haematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective.
Mugisha JO, Shafer LA, Van der Paal L. Anaemia in a rural Ugandan HIV cohort: prevalence at enrolment, incidence, diagnosis and associated factors. Trop Med Int Health 2008;13:788–94.
Erhabor O, Ejele OA, Nwauche CA. Some hematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med 2005;14:33
Firnhaber C, Smeaton L, Saukila N. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis 2010;14:e1088–92.
Kimura S, Matsuda J, Ikematsu S. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS 1990;4:1251–5